Premarket roundup: Progressive, ImClone

Among the premarket stories for Monday, June 2, from AP Financial News:

NEW YORK (AP) _ A Friedman Billings Ramsey analyst expects larger profits for Progressive as Americans cut back on their driving, lowering the amount of accident claims the insurer has to pay.

NEW YORK (AP) _ Shares of ImClone Systems Inc. fell in premarket trading Monday as investors took a dim view of trial data for its drug Erbitux as a treatment for lung cancer and colorectal cancer.

NEW YORK (AP) _ Shares of Yingli Green Energy Holding Co. advanced in premarket trading Monday after Citi Investment Research said the company will benefit from a smaller-than-expected cut in solar subsidies in Germany.

NEW YORK (AP) _ Shares of Wachovia Corp. fell in premarket trading Monday after its board of directors asked Chief Executive Ken Thompson to retire.

HAWTHORNE, N.Y. (AP) _ Shares of Acorda Therapeutics Inc. soared in premarket trading Monday after the biotechnology company said its multiple sclerosis drug candidate Fampridine-SR met its goal in a late-stage trial.

Comment (0)
Recommended (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 656003, ~/articles/articlehandler.aspx, 10/12/2008 6:11:40 AM,

Related Tickers

Acorda Therapeutics, Inc.

ACOR Down! $16.41 -0.87 (-5.03%) 4:00 PM
CAPS Rating:
136 Outperforms
92 Underperforms
Rate This Stock

Major Indices

S&P 500899.22 -1.18%
DJIA8,451.19 -1.49%
NASD1,649.51+0.27%
Updated: 4:09:31 PM
Sponsored by:

The Motley Poll

What do you think will be the best performing sector over the next six months?

Sponsored by: